MD / MS / DNB · MD Pharmacology

Population pharmacokinetics

Population pharmacokinetics describes variation in drug exposure across a population using models that distinguish typical parameters from between-person and residual variation.

Open interactive lesson & self-check ↗

Population pharmacokinetics — specialty learning map

Original conceptual SVG · scalable
ORIGINAL SPECIALTY CONCEPT MAP · NOT A DIAGNOSTIC IMAGEStructural modelcompartments and clearanceVariabilitybetween-subject differencesSampling and estimationdata limitationsApplication and validationpredictive performancePopulation pharmacokineticsFOUR CONNECTED DOMAINS

Original overview diagram showing four related domains. This is not a literal anatomy drawing, histologic image or clinical decision rule.

Concept 01

Structural model

An appropriate model specifies absorption, distribution and elimination behavior using parameters such as clearance and volume of distribution.

Concept 02

Variability

Body size, organ function, maturation, genotype and interacting drugs can explain some pharmacokinetic variability.

Concept 03

Sampling and estimation

Sparse and rich concentration measurements require suitable analysis methods, assay validation and transparent handling of missing or below-quantification observations.

Concept 04

Application and validation

External evaluation and uncertainty assessment are required before a population model informs clinical drug-monitoring decisions.

Education / safety note: This map does not authorize any patient dosing or drug concentration target; clinical application requires validated models and professional review.

Reference and next reading

Explore the original curriculum and publisher-hosted resources for full-depth reading; this note is an original schematic introduction, not an exhaustive chapter.

Official / publisher source: NBEMS DNB broad-specialty curricula ↗Official / publisher source: NCBI Bookshelf ↗Official / publisher source: PubMed ↗